AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030.
AstraZeneca to invest $50 bln in US as pharma tariffs loom
view original post
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030.